Acute chest syndrome and COVID-19 in sickle cell disease pediatric patients

AUTOR(ES)

Elia, Gabriella Mafra; Angel, Andrea; Regacini, Rodrigo; Nais, Rafaela Pilotto; Santos, Andréia Regina Augusto dos; Vieira, Pedro Paulo Macarini Gonçalves; Braga, Josefina Aparecida Pellegrini

FONTE

Hematol., Transfus. Cell Ther.

DATA DE PUBLICAÇÃO

2021-03

RESUMO

ABSTRACT Autoimmune diseases are an important field for the development of bone marrow transplantation, or hematopoietic stem cell transplantation. In Europe alone, almost 3000 procedures have been registered so far. The Brazilian Society for Bone Marrow Transplantation (Sociedade Brasileira de Transplantes de Medula Óssea) organized consensus meetings for the Autoimmune Diseases Group, to review the available literature on hematopoietic stem cell transplantation for autoimmune diseases, aiming to gather data that support the procedure for these patients. Three autoimmune diseases for which there are evidence-based indications for hematopoietic stem cell transplantation are multiple sclerosis, systemic sclerosis and Crohn's disease. The professional stem cell transplant societies in America, Europe and Brazil (Sociedade Brasileira de Transplantes de Medula Óssea) currently consider hematopoietic stem cell transplantation as a therapeutic modality for these three autoimmune diseases. This article reviews the evidence available.

Documentos Relacionados

• COVID-19 as a trigger of acute chest syndrome in a pregnant woman with sickle cell anemia
• Practical Approach to Acute Coronary Syndrome in Patients with COVID-19
• Pulmonary artery pressure and the acute chest syndrome in homozygous sickle cell disease.
• Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease
• Covid-19 and Metabolic Syndrome